Novartis Deutschland GmbH

Advancing Three Cancer Drugs, Salmedix Takes Aim At $86M IPO.
BIOWORLD Today; 11/3/2009; 1468 words; ...S. and Canada from Fujisawa Deutschland GmbH, of Munich, Germany. Salmedix...Europe sponsored by Fujisawa Deutschland. Salmedix intends to market...Genentech Inc.), Gleevec (Novartis AG), Campath (ILEX Oncology...

Catch the Rising Stars of Medical Technology in Paris, France, at the Upcoming Investment-In-Innovation (In3) Europe Conference, April 29-30, 2009, Paris, France.(Conference news)
Business Wire; 4/7/2009; 1232 words; ...Solutions; Invendo Medical GmbH; Lifenova Biomedical...Works; mNemoScience GmbH; MTM Laboratories...Medtronic Europe, Novartis Pharmsa AG, Sarl, Paul...Paris, Sanofi-Aventis Deutschland GmbH, Sofinnova Partners...

TEMIS Text Analytics Solution Luxid(R) for Automated Knowledge Discovery in Pharma Research.
PR Newswire; 9/29/2008; 924 words; ...says Stefan Geissler, Managing Director of TEMIS Deutschland GmbH. "Merck KGaA is a determined and creative client...technology has attracted major organizations such as EMC, Novartis, Sanofi-Aventis, Boehringer Ingelheim, BASF...

Identify the Key Factors Influencing the Vitamins and Dietary Supplements Market in Austria.
Business Wire; 3/27/2007; 1035 words; ...amp; Co KG - Wyeth-Lederle Pharma GmbH - Queisser Pharma GmbH & Co - Novartis Consumer - Health-Gebro GmbH - STADA Arzneimittel AG - Genericon...Sanochemia Pharmazeutika AG - Pharmacia Deutschland GmbH For more information visit http...

Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) are Classified inside 2006 Global Strategic Business Report.
Business Wire; 11/27/2006; 1177 words; ...Inc (USA) Newron Pharmaceuticals SpA (Italy) Novartis AG (Switzerland) Novartis Pharmaceuticals Corporation (USA) Novartis Deutschland GmbH (Germany) Novartis Pharma GmbH (Germany) NsGene A/S (Denmark) Nymox Pharmaceutical Corporation...